Last updated: October 30, 2026
All content, market data, IPO schedules, bidding stats, allotment statuses, subscription figures, and financial ratios displayed on IPO Pricealerter (accessible at pricealerter.in) are compiled exclusively for general knowledge and educational research. Investors must consult an independent, SEBI-registered financial advisor before making any financial commitment or stock market investment.
Grey Market Premium (GMP) is an unofficial, unregulated over-the-counter (OTC) indication traded informally before stock listing. It is not approved, verified, monitored, or endorsed by stock exchanges (NSE / BSE) or regulatory authorities (SEBI). GMP numbers are volatile, based on market sentiment, and subject to swift reversals. A positive GMP does not ensure listing day gains or price stability. Never make investment choices based solely on GMP figures.
IPO Pricealerter aggregates public information from official exchange portals (NSE India, BSE India), market news aggregators (Chittorgarh, IPO Watch), registrar portals (Link Intime, KFin Technologies, Bigshare Services, Maashitla, MUFG Link/MPMS, Purva Share, Skyline, Mas Services), and Red Herring Prospectuses (RHP). While we strive for absolute accuracy and update stats frequently, figures may experience delays, revisions, or technical errors. Users are strongly advised to verify details with official offer documents (DRHP / RHP) filed with SEBI.
Equity investments, especially in Initial Public Offerings (both Mainboard and SME segments), carry significant risk, including partial or total capital loss. SME IPOs typically have minimum lot requirements of ₹1,00,000 to ₹1,50,000 and lower liquidity compared to Mainboard equities. Investors are solely responsible for their financial decisions.
Pricealerter / IPO Pricealerter is an independent information website and is not affiliated with, endorsed by, or sponsored by NSE, BSE, SEBI, or any IPO issuing company or registrar unless explicitly stated.
For data corrections, official registrar link updates, or regulatory inquiries, contact [email protected].